JP2019501145A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501145A5 JP2019501145A5 JP2018528650A JP2018528650A JP2019501145A5 JP 2019501145 A5 JP2019501145 A5 JP 2019501145A5 JP 2018528650 A JP2018528650 A JP 2018528650A JP 2018528650 A JP2018528650 A JP 2018528650A JP 2019501145 A5 JP2019501145 A5 JP 2019501145A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cancer
- composition according
- checkpoint inhibitor
- fucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562263228P | 2015-12-04 | 2015-12-04 | |
| US62/263,228 | 2015-12-04 | ||
| US201662308583P | 2016-03-15 | 2016-03-15 | |
| US62/308,583 | 2016-03-15 | ||
| US201662321857P | 2016-04-13 | 2016-04-13 | |
| US62/321,857 | 2016-04-13 | ||
| PCT/US2016/064783 WO2017096274A1 (en) | 2015-12-04 | 2016-12-02 | Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501145A JP2019501145A (ja) | 2019-01-17 |
| JP2019501145A5 true JP2019501145A5 (https=) | 2020-01-16 |
| JP6906520B2 JP6906520B2 (ja) | 2021-07-21 |
Family
ID=58797961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018528650A Expired - Fee Related JP6906520B2 (ja) | 2015-12-04 | 2016-12-02 | チェックポイント阻害剤と組みわせて２−デオキシ−２−フルオロ−ｌ−フコースを用いる癌治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180353524A1 (https=) |
| EP (1) | EP3383404A4 (https=) |
| JP (1) | JP6906520B2 (https=) |
| KR (1) | KR20180086233A (https=) |
| CN (1) | CN108289903B (https=) |
| AU (1) | AU2016362993A1 (https=) |
| BR (1) | BR112018011261A2 (https=) |
| CA (1) | CA3005997A1 (https=) |
| EA (1) | EA201891340A1 (https=) |
| IL (1) | IL259479B (https=) |
| MX (1) | MX385283B (https=) |
| SG (2) | SG11201804263PA (https=) |
| WO (1) | WO2017096274A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2625768C2 (ru) | 2010-08-05 | 2017-07-18 | Сиэтл Дженетикс, Инк. | Способы ингибирования фукозилирования белков in vivo с использованием аналогов фукозы |
| JP7066696B2 (ja) | 2016-10-11 | 2022-05-13 | アジェナス インコーポレイテッド | 抗ｌａｇ－３抗体及びその使用方法 |
| MX2019014584A (es) * | 2017-06-07 | 2020-02-07 | Seattle Genetics Inc | Celulas t con fucosilacion de superficie reducida y metodos para preparar y usar las mismas. |
| WO2019075449A1 (en) * | 2017-10-13 | 2019-04-18 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | FUCOSYLATION AND IMMUNOSURVEILLANCE OF MELANOMA |
| JP2021534196A (ja) | 2018-08-23 | 2021-12-09 | シージェン インコーポレイテッド | 抗ｔｉｇｉｔ抗体 |
| AU2019402923A1 (en) * | 2018-12-19 | 2021-07-15 | Seagen Inc. | Controlled fucosylation of antibodies |
| WO2021034774A1 (en) * | 2019-08-16 | 2021-02-25 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Fucosylation and immune modulation in cancer |
| CN111973749B (zh) * | 2020-09-07 | 2023-03-21 | 威海人生药业集团股份有限公司 | 一种抗肿瘤免疫治疗的药物组合物 |
| BR112023018676A2 (pt) | 2021-03-18 | 2023-10-10 | Seagen Inc | Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco |
| US20240197761A1 (en) * | 2021-04-16 | 2024-06-20 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Fucosylation and immune modulation in cancer |
| CN113274502B (zh) * | 2021-05-05 | 2023-01-03 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 用于特定型三阴乳腺癌免疫治疗的组合物 |
| WO2022236017A1 (en) * | 2021-05-06 | 2022-11-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | L-fucose and anti-androgen receptor therapy for treatment of cancer |
| CN113413465B (zh) * | 2021-06-15 | 2022-06-03 | 北京大学 | 岩藻糖基化抑制剂在抗癌导致炎症中的应用 |
| CN115466297B (zh) * | 2022-08-25 | 2023-07-07 | 青岛农业大学 | L-岩藻糖的应用以及动物饲料 |
| WO2024077106A2 (en) * | 2022-10-04 | 2024-04-11 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Leveraging l-fucose-mediated signaling to induce monocyte-derived dendritic cell polarization |
| WO2024191807A1 (en) | 2023-03-10 | 2024-09-19 | Seagen Inc. | Methods of treating cancer with anti-tigit antibodies |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2625768C2 (ru) | 2010-08-05 | 2017-07-18 | Сиэтл Дженетикс, Инк. | Способы ингибирования фукозилирования белков in vivo с использованием аналогов фукозы |
| IL292510A (en) | 2013-11-05 | 2022-06-01 | Cognate Bioservices Inc | Combinations of checkpoint inhibitors and therapeutics to treat cancer |
-
2016
- 2016-12-02 US US15/781,256 patent/US20180353524A1/en not_active Abandoned
- 2016-12-02 SG SG11201804263PA patent/SG11201804263PA/en unknown
- 2016-12-02 WO PCT/US2016/064783 patent/WO2017096274A1/en not_active Ceased
- 2016-12-02 CA CA3005997A patent/CA3005997A1/en not_active Abandoned
- 2016-12-02 KR KR1020187017824A patent/KR20180086233A/ko not_active Withdrawn
- 2016-12-02 BR BR112018011261A patent/BR112018011261A2/pt not_active Application Discontinuation
- 2016-12-02 SG SG10202005298RA patent/SG10202005298RA/en unknown
- 2016-12-02 AU AU2016362993A patent/AU2016362993A1/en not_active Abandoned
- 2016-12-02 CN CN201680071076.0A patent/CN108289903B/zh not_active Expired - Fee Related
- 2016-12-02 JP JP2018528650A patent/JP6906520B2/ja not_active Expired - Fee Related
- 2016-12-02 EA EA201891340A patent/EA201891340A1/ru unknown
- 2016-12-02 MX MX2018006674A patent/MX385283B/es unknown
- 2016-12-02 EP EP16871645.4A patent/EP3383404A4/en not_active Withdrawn
-
2018
- 2018-05-21 IL IL259479A patent/IL259479B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019501145A5 (https=) | ||
| Vacchelli et al. | Trial watch: Tumor-targeting monoclonal antibodies for oncological indications | |
| JP2018530554A5 (https=) | ||
| JP7458981B2 (ja) | 抗体－薬物コンジュゲートとチューブリン阻害剤の組み合わせ | |
| JP2016540042A5 (https=) | ||
| RU2019120400A (ru) | Композиции и способы, связанные с клеточными системами для проникновения в солидные опухоли | |
| JP2017506227A5 (https=) | ||
| JP2019519499A5 (https=) | ||
| JP2016187356A5 (https=) | ||
| JP2017537620A5 (https=) | ||
| JP2019501151A5 (https=) | ||
| HRP20230517T1 (hr) | Kombinacija anti-pd-1 antitijela i radijacijske terapije za liječenje raka | |
| RU2009132674A (ru) | Комбинированная терапия с использованием ингибиторов ангиогенеза | |
| HRP20171758T1 (hr) | Kombinacija dr5 agonista i anti-pd-1 antagonista i načini primjene | |
| JP2017530950A5 (https=) | ||
| JP2018508525A5 (https=) | ||
| ME00425B (me) | Liječenje sa anti-vegf antitijelima | |
| JP2022189827A (ja) | 癌を治療するための免疫調節剤と組み合わせた低酸素活性化型プロドラッグの投与 | |
| JP2026021441A (ja) | 抗体－薬物コンジュゲート投与による転移性脳腫瘍の治療 | |
| JPWO2022270524A5 (https=) | ||
| Nishibata et al. | Effect of anti-claudin 18.2 monoclonal antibody zolbetuximab alone or combined with chemotherapy or programmed cell death-1 blockade in syngeneic and xenograft gastric cancer models | |
| Shannon et al. | Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma | |
| MX2020009614A (es) | Combinaciones farmaceuticas. | |
| Cui et al. | Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer | |
| JP6909161B2 (ja) | 抗ｆｇｆｒ４抗体および胆汁酸捕捉剤の組み合わせ |